A quick Google check reveals that there is plenty of literature available for monitoring trace levels of OMCTS. After all, it and it's metabolites were a significant part of the ruptured breast implant scare of a decade or so ago - hence the low acceptable concentrations. The column you have, even though a silicone stationary phase, appears suitable, but probably not ideal.
I would spend a little time looking at what others have done, and would be rather loathe to use a polar column, and would especially try for the thinnest film possible, even down to 0.1 um, to keep temperatures low.
I would consult column manufacturers, and find which stationary phase they woudl recommend. PLOT columns are suitable alternatives to packed columns.
Withe regard to septum, I would just use a cork borer and a crimp vial cap liner made from butyl rubber or viton, and accept it will only last a few injections.
OMCTS does react with active glass surfaces, so you need to ensure your inlet system is as inert as possible, with minimal surface area.
However, the column probably should be run isothermally ( 75 - 90C ) for the analytical sequence, every time you ramp up the temperature, you may create more unwanted background.
Also, because your molecule reacts with glass, then you should try to minimise injector temperature ( I'd start with 150C, changing sample solvent if necessary ), and perhaps reducing interface line temperature -after all it's fairly volatile ( ~175C ).
Bruce Hamilton